Patents by Inventor Elkan R. Gamzu

Elkan R. Gamzu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RAPID ONSET AND SHORT TERM MODAFINIL COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20110306669
    Abstract: Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual.
    Type: Application
    Filed: August 22, 2011
    Publication date: December 15, 2011
    Inventors: Eyal S. Ron, Neal M. Farber, Daniel E. Katzman, Elkan R. Gamzu
  • High potency dopaminergic treatment of neurological impairment associated with brain injury
    Patent number: 7943632
    Abstract: Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual apomorphine. Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual at least 1000 mg or more of L-dopa (levodopa) per day. The use of potent dopaminergic agents to stimulate emergence from an altered consciousness state, such as a coma, is disclosed.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: May 17, 2011
    Assignee: NeuroHealing Pharmaceuticals, Inc.
    Inventors: Daniel E. Katzman, Elkan R. Gamzu, Neal M. Farber, Esteban A. Fridman, Marcelo Merello
  • Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof
    Publication number: 20090123545
    Abstract: Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual.
    Type: Application
    Filed: July 21, 2006
    Publication date: May 14, 2009
    Inventors: Eyal S. Ron, Neal M. Farber, Daniel E. Katzman, Elkan R. Gamzu